The Shield Echodyne acquisition, announced on November 5, 2026, is valued at $5.3 billion and will bring Echodyne Corp., a radar maker based in Kirkland, Washington, under the ownership of defense technology company Shield. Echodyne’s radars are already built into hundreds of counter-drone and security systems used by defense, government, and commercial customers in more than 40 countries. Both companies say they expect triple-digit revenue growth during the current fiscal year, and Shield plans to use the purchase to push its Mission Systems business further into the radar and counter-drone markets.
To pay for the deal, Shield is raising $2.5 billion from three sources. The two largest pieces are $1 billion in Series H funding, which sets the company’s post-money valuation at $28.8 billion, and a separate $1 billion structured equity investment from funds managed by Blackstone. The final $500 million comes from debt financing, with JPMorgan Chase Bank, N.A. acting as Sole Arranger. Of the total deal value, $4.8 billion will be paid and issued when the transaction closes, while up to $500 million more depends on Echodyne reaching performance targets the two sides have agreed on.
How the Shield Echodyne Acquisition Expands Drone Radar
The deal fills out Shield’s Mission Systems unit with software-defined radars that support counter-unmanned aircraft systems, known as C-UAS, which are designed to find, follow, and defeat drones. Echodyne contributes its metamaterials-based radar technology along with its engineering team and manufacturing capacity. Its compact, solid-state radars are built around a patented design called Metamaterials Electronically Scanned Array, or MESA. Shield already develops Hivemind autonomy software, Aechelon simulation for training and testing, and the V-BAT and X-BAT autonomous systems.
“We are building a new-generation defense technology company consisting of three fast-growing, high-margin, mutually supporting business units: autonomy software, autonomous systems, and mission systems,” said Gary Steele, CEO of Shield. “The acquisition of Echodyne dramatically accelerates our efforts to meet growing customer demand for multi-mission capabilities, provides increased access to a rapidly expanding counter-drone industry, and further diversifies our revenue streams with sustained, compelling growth for the combined company.” Gary Steele, CEO of Shield
Echodyne’s sensors appear across a wide range of military hardware. They are integrated on a large number of remote weapon stations, high-energy lasers, and high-power microwave systems, and they help steer interceptors toward incoming drones. In September, the company won a contract with a $250 million ceiling from Joint Interagency Task Force 401 to provide counter-drone radar for U.S. and allied forces. Outside the military, civilian operators use the same radars to keep unauthorized drones away from stadiums and airports, and police and fire departments rely on them to fly their own drones safely in shared airspace.
What Changes for Echodyne Under Shield Ownership
Once the Shield Echodyne acquisition closes, Echodyne plans to speed up its current strategy of selling high-performance radar systems to integrators and end customers in the defense, government, and commercial sectors. Its team will stay in place, and MESA radars will still be sold as standalone products. Eben Frankenberg, Echodyne’s CEO, will report directly to Steele and keep responsibility for the company’s products, manufacturing operations, and work with partners and customers.
The purchase also widens Shield’s presence in Washington state. Echodyne, which is based in Kirkland, recently opened an 86,350-square-foot manufacturing facility, a $40 million investment that will be able to turn out about 30,000 radars per year. Shield had already chosen Washington in September as the production home for X-BAT, one of its autonomous systems.
The Series H round is co-led by Disruptive and Innovation X Capital. Other participants include Advent, the Strategic Investment Group of JPMorganChase’s Security and Resiliency Initiative, Snowpoint Ventures, Apandion, and Center15 Capital, among others. Shield says the Series H money will mainly be used to fund the Shield Echodyne acquisition.
The transaction is expected to close in early 2027, once the required regulatory approvals are received and other customary closing conditions are met. J.P. Morgan Securities LLC served as exclusive financial advisor to Shield on the acquisition, Wachtell, Lipton, Rosen & Katz acted as its legal advisor, and Covington & Burling LLP advised on regulatory and business diligence matters. Sullivan & Cromwell LLP was Shield’s legal advisor on the financing. On Echodyne’s side, Morgan Stanley & Co. LLC and Robert W. Baird & Co. Incorporated served as financial advisors, and Fenwick & West LLP provided legal counsel.
